Harold E. Selick - Apr 10, 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Asif Ali, Attorney-in-Fact for Harold E. Selick
Stock symbol
PTGX
Transactions as of
Apr 10, 2023
Transactions value $
$5,391
Form type
4
Date filed
4/11/2023, 07:18 PM
Previous filing
Jan 18, 2023
Next filing
Oct 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Options Exercise $5.39K +6.2K +40.47% $0.87 21.5K Apr 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Options Exercise $0 -6.2K -100% $0.00* 0 Apr 10, 2023 Common Stock 6.2K $0.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the "Lock-up Date") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date.
F2 The stock option is vested in full.